Asthma Trial, Recruiting NCT06783101 Sponsor: Children's Hospital Los Angeles Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06783101
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The participant must be a young person between the ages of 10 and 17 years old
  • The participant must have a diagnosis of mild-to-moderate intellectual disability and/or a developmental disability, which may include autism
  • The participant must have a diagnosis of moderate-to-severe asthma
  • The participant's parent or legal guardian must be willing to answer questions about their child
  • Both the parent or legal guardian and the young person must be able to understand what the study involves and follow the study rules for its entire duration
  • The participant and/or their family must speak English or Spanish
  • The participant must not currently be involved in any other studies that use digital inhalers
  • Both male and female participants are welcome, and no specific birth control requirements apply
  • The participant must currently use one of the following inhalers: Ventolin HFA, ProAir HFA, Advair HFA, Flovent HFA, Xopenex HFA, Symbicort HFA, Atrovent HFA, Proventil HFA, Alvesco HFA, Dulera HFA, or Asmanex HFA

Who may not be able to join:

  • Participants who have a serious health condition or limited life expectancy that would make it difficult to properly take part in, be treated during, or be followed up on throughout the trial
  • Participants whose parent, legal guardian, or representative is unwilling or unable to give written consent to join the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Larry Yin, MD, MSPH, Children's Hospital Los Angeles

Phone: 323-669-2534

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital Los Angeles
Registry
ClinicalTrials.gov
Start date
13 August 2024
Est. completion
1 April 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of smart inhaler device; Acceptability of smart inhaler; Usability of smart inhaler

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov